Lipopeptide particles as the immunologically active component of CTL inducing vaccines
- 1 February 1999
- Vol. 17 (7-8) , 675-685
- https://doi.org/10.1016/s0264-410x(98)00250-3
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzeesEuropean Journal of Immunology, 1997
- Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cellsImmunology, 1996
- Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesVaccine, 1996
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex MoleculesScience, 1990
- Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.The Journal of Experimental Medicine, 1987
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981